0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Swine Epidemic Diarrhea Vaccines Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-20W5774
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Swine Epidemic Diarrhea Vaccines Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Swine Epidemic Diarrhea Vaccines Market Research Report 2025

Code: QYRE-Auto-20W5774
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Swine Epidemic Diarrhea Vaccines Market Size

The global market for Swine Epidemic Diarrhea Vaccines was valued at US$ 1487 million in the year 2024 and is projected to reach a revised size of US$ 2082 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Swine Epidemic Diarrhea Vaccines Market

Swine Epidemic Diarrhea Vaccines Market

Swine epidemic diarrhea virus (PEDV) is the causative agent of porcine epidemic diarrhea (PED), an acute and highly contagious enteric viral disease. 
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Swine Epidemic Diarrhea Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Epidemic Diarrhea Vaccines.
The Swine Epidemic Diarrhea Vaccines market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Epidemic Diarrhea Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Swine Epidemic Diarrhea Vaccines companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Swine Epidemic Diarrhea Vaccines Market Report

Report Metric Details
Report Name Swine Epidemic Diarrhea Vaccines Market
Accounted market size in year US$ 1487 million
Forecasted market size in 2031 US$ 2082 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Piglets
  • Adults Pigs
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CAVAC, Green Cross Veterinary Products, Harrisvaccines, Inc., Komipharm, Nisseiken, Qilu Animal Health, Zoetis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Swine Epidemic Diarrhea Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Swine Epidemic Diarrhea Vaccines Market growing?

Ans: The Swine Epidemic Diarrhea Vaccines Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Swine Epidemic Diarrhea Vaccines Market size in 2031?

Ans: The Swine Epidemic Diarrhea Vaccines Market size in 2031 will be US$ 2082 million.

Who are the main players in the Swine Epidemic Diarrhea Vaccines Market report?

Ans: The main players in the Swine Epidemic Diarrhea Vaccines Market are CAVAC, Green Cross Veterinary Products, Harrisvaccines, Inc., Komipharm, Nisseiken, Qilu Animal Health, Zoetis

What are the Application segmentation covered in the Swine Epidemic Diarrhea Vaccines Market report?

Ans: The Applications covered in the Swine Epidemic Diarrhea Vaccines Market report are Piglets, Adults Pigs

What are the Type segmentation covered in the Swine Epidemic Diarrhea Vaccines Market report?

Ans: The Types covered in the Swine Epidemic Diarrhea Vaccines Market report are Live Vaccines, Killed Vaccines

Recommended Reports

Animal Vaccine Markets

Swine Disease Solutions

Veterinary Pharmaceuticals

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market by Application
1.3.1 Global Swine Epidemic Diarrhea Vaccines Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Piglets
1.3.3 Adults Pigs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Swine Epidemic Diarrhea Vaccines Market Perspective (2020-2031)
2.2 Global Swine Epidemic Diarrhea Vaccines Growth Trends by Region
2.2.1 Global Swine Epidemic Diarrhea Vaccines Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Swine Epidemic Diarrhea Vaccines Historic Market Size by Region (2020-2025)
2.2.3 Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Region (2026-2031)
2.3 Swine Epidemic Diarrhea Vaccines Market Dynamics
2.3.1 Swine Epidemic Diarrhea Vaccines Industry Trends
2.3.2 Swine Epidemic Diarrhea Vaccines Market Drivers
2.3.3 Swine Epidemic Diarrhea Vaccines Market Challenges
2.3.4 Swine Epidemic Diarrhea Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue
3.1.1 Global Top Swine Epidemic Diarrhea Vaccines Players by Revenue (2020-2025)
3.1.2 Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Players (2020-2025)
3.2 Global Swine Epidemic Diarrhea Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Swine Epidemic Diarrhea Vaccines Revenue
3.4 Global Swine Epidemic Diarrhea Vaccines Market Concentration Ratio
3.4.1 Global Swine Epidemic Diarrhea Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Swine Epidemic Diarrhea Vaccines Revenue in 2024
3.5 Global Key Players of Swine Epidemic Diarrhea Vaccines Head office and Area Served
3.6 Global Key Players of Swine Epidemic Diarrhea Vaccines, Product and Application
3.7 Global Key Players of Swine Epidemic Diarrhea Vaccines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Swine Epidemic Diarrhea Vaccines Breakdown Data by Type
4.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Type (2020-2025)
4.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2026-2031)
5 Swine Epidemic Diarrhea Vaccines Breakdown Data by Application
5.1 Global Swine Epidemic Diarrhea Vaccines Historic Market Size by Application (2020-2025)
5.2 Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Swine Epidemic Diarrhea Vaccines Market Size (2020-2031)
6.2 North America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025)
6.4 North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Swine Epidemic Diarrhea Vaccines Market Size (2020-2031)
7.2 Europe Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025)
7.4 Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size (2020-2031)
8.2 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2020-2025)
8.4 Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Swine Epidemic Diarrhea Vaccines Market Size (2020-2031)
9.2 Latin America Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025)
9.4 Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size (2020-2031)
10.2 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025)
10.4 Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CAVAC
11.1.1 CAVAC Company Details
11.1.2 CAVAC Business Overview
11.1.3 CAVAC Swine Epidemic Diarrhea Vaccines Introduction
11.1.4 CAVAC Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.1.5 CAVAC Recent Development
11.2 Green Cross Veterinary Products
11.2.1 Green Cross Veterinary Products Company Details
11.2.2 Green Cross Veterinary Products Business Overview
11.2.3 Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Introduction
11.2.4 Green Cross Veterinary Products Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.2.5 Green Cross Veterinary Products Recent Development
11.3 Harrisvaccines, Inc.
11.3.1 Harrisvaccines, Inc. Company Details
11.3.2 Harrisvaccines, Inc. Business Overview
11.3.3 Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Introduction
11.3.4 Harrisvaccines, Inc. Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.3.5 Harrisvaccines, Inc. Recent Development
11.4 Komipharm
11.4.1 Komipharm Company Details
11.4.2 Komipharm Business Overview
11.4.3 Komipharm Swine Epidemic Diarrhea Vaccines Introduction
11.4.4 Komipharm Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.4.5 Komipharm Recent Development
11.5 Nisseiken
11.5.1 Nisseiken Company Details
11.5.2 Nisseiken Business Overview
11.5.3 Nisseiken Swine Epidemic Diarrhea Vaccines Introduction
11.5.4 Nisseiken Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.5.5 Nisseiken Recent Development
11.6 Qilu Animal Health
11.6.1 Qilu Animal Health Company Details
11.6.2 Qilu Animal Health Business Overview
11.6.3 Qilu Animal Health Swine Epidemic Diarrhea Vaccines Introduction
11.6.4 Qilu Animal Health Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.6.5 Qilu Animal Health Recent Development
11.7 Zoetis
11.7.1 Zoetis Company Details
11.7.2 Zoetis Business Overview
11.7.3 Zoetis Swine Epidemic Diarrhea Vaccines Introduction
11.7.4 Zoetis Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
11.7.5 Zoetis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Live Vaccines
 Table 3. Key Players of Killed Vaccines
 Table 4. Global Swine Epidemic Diarrhea Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Swine Epidemic Diarrhea Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2020-2025)
 Table 8. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Swine Epidemic Diarrhea Vaccines Market Share by Region (2026-2031)
 Table 10. Swine Epidemic Diarrhea Vaccines Market Trends
 Table 11. Swine Epidemic Diarrhea Vaccines Market Drivers
 Table 12. Swine Epidemic Diarrhea Vaccines Market Challenges
 Table 13. Swine Epidemic Diarrhea Vaccines Market Restraints
 Table 14. Global Swine Epidemic Diarrhea Vaccines Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Swine Epidemic Diarrhea Vaccines Market Share by Players (2020-2025)
 Table 16. Global Top Swine Epidemic Diarrhea Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Epidemic Diarrhea Vaccines as of 2024)
 Table 17. Ranking of Global Top Swine Epidemic Diarrhea Vaccines Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Swine Epidemic Diarrhea Vaccines Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Swine Epidemic Diarrhea Vaccines, Headquarters and Area Served
 Table 20. Global Key Players of Swine Epidemic Diarrhea Vaccines, Product and Application
 Table 21. Global Key Players of Swine Epidemic Diarrhea Vaccines, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Swine Epidemic Diarrhea Vaccines Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2020-2025)
 Table 25. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Type (2026-2031)
 Table 27. Global Swine Epidemic Diarrhea Vaccines Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2020-2025)
 Table 29. Global Swine Epidemic Diarrhea Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Swine Epidemic Diarrhea Vaccines Revenue Market Share by Application (2026-2031)
 Table 31. North America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size by Country (2026-2031) & (US$ Million)
 Table 46. CAVAC Company Details
 Table 47. CAVAC Business Overview
 Table 48. CAVAC Swine Epidemic Diarrhea Vaccines Product
 Table 49. CAVAC Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 50. CAVAC Recent Development
 Table 51. Green Cross Veterinary Products Company Details
 Table 52. Green Cross Veterinary Products Business Overview
 Table 53. Green Cross Veterinary Products Swine Epidemic Diarrhea Vaccines Product
 Table 54. Green Cross Veterinary Products Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 55. Green Cross Veterinary Products Recent Development
 Table 56. Harrisvaccines, Inc. Company Details
 Table 57. Harrisvaccines, Inc. Business Overview
 Table 58. Harrisvaccines, Inc. Swine Epidemic Diarrhea Vaccines Product
 Table 59. Harrisvaccines, Inc. Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 60. Harrisvaccines, Inc. Recent Development
 Table 61. Komipharm Company Details
 Table 62. Komipharm Business Overview
 Table 63. Komipharm Swine Epidemic Diarrhea Vaccines Product
 Table 64. Komipharm Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 65. Komipharm Recent Development
 Table 66. Nisseiken Company Details
 Table 67. Nisseiken Business Overview
 Table 68. Nisseiken Swine Epidemic Diarrhea Vaccines Product
 Table 69. Nisseiken Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 70. Nisseiken Recent Development
 Table 71. Qilu Animal Health Company Details
 Table 72. Qilu Animal Health Business Overview
 Table 73. Qilu Animal Health Swine Epidemic Diarrhea Vaccines Product
 Table 74. Qilu Animal Health Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 75. Qilu Animal Health Recent Development
 Table 76. Zoetis Company Details
 Table 77. Zoetis Business Overview
 Table 78. Zoetis Swine Epidemic Diarrhea Vaccines Product
 Table 79. Zoetis Revenue in Swine Epidemic Diarrhea Vaccines Business (2020-2025) & (US$ Million)
 Table 80. Zoetis Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Swine Epidemic Diarrhea Vaccines Picture
 Figure 2. Global Swine Epidemic Diarrhea Vaccines Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Swine Epidemic Diarrhea Vaccines Market Share by Type: 2024 VS 2031
 Figure 4. Live Vaccines Features
 Figure 5. Killed Vaccines Features
 Figure 6. Global Swine Epidemic Diarrhea Vaccines Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Swine Epidemic Diarrhea Vaccines Market Share by Application: 2024 VS 2031
 Figure 8. Piglets Case Studies
 Figure 9. Adults Pigs Case Studies
 Figure 10. Swine Epidemic Diarrhea Vaccines Report Years Considered
 Figure 11. Global Swine Epidemic Diarrhea Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Swine Epidemic Diarrhea Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Swine Epidemic Diarrhea Vaccines Market Share by Region: 2024 VS 2031
 Figure 14. Global Swine Epidemic Diarrhea Vaccines Market Share by Players in 2024
 Figure 15. Global Top Swine Epidemic Diarrhea Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Epidemic Diarrhea Vaccines as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Swine Epidemic Diarrhea Vaccines Revenue in 2024
 Figure 17. North America Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Swine Epidemic Diarrhea Vaccines Market Share by Country (2020-2031)
 Figure 19. United States Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Swine Epidemic Diarrhea Vaccines Market Share by Country (2020-2031)
 Figure 23. Germany Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Swine Epidemic Diarrhea Vaccines Market Share by Region (2020-2031)
 Figure 31. China Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Swine Epidemic Diarrhea Vaccines Market Share by Country (2020-2031)
 Figure 39. Mexico Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Swine Epidemic Diarrhea Vaccines Market Share by Country (2020-2031)
 Figure 43. Turkey Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Swine Epidemic Diarrhea Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. CAVAC Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 47. Green Cross Veterinary Products Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 48. Harrisvaccines, Inc. Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 49. Komipharm Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 50. Nisseiken Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 51. Qilu Animal Health Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 52. Zoetis Revenue Growth Rate in Swine Epidemic Diarrhea Vaccines Business (2020-2025)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS